<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="tk2-mtddepl" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">tk2-mtddepl</book-part-id>
      <title-group>
        <title><italic toggle="yes">TK2</italic>-Related Mitochondrial DNA Depletion Syndrome, Myopathic Form</title>
        <alt-title alt-title-type="alt-title">Synonym: <italic toggle="yes">TK2</italic>-Related Mitochondrial DNA Depletion Myopathy</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chanprasert</surname>
            <given-names>Sirisak</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Baylor College of Medicine<break/>Houston, Texas</aff>
          <email>chanpras@bcm.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Wong</surname>
            <given-names>Lee-Jun C</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Baylor College of Medicine<break/>Houston, Texas</aff>
          <email>ljwong@bcm.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Wang</surname>
            <given-names>Jing</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Baylor College of Medicine<break/>Houston, Texas</aff>
          <email>jwang7@bcm.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Scaglia</surname>
            <given-names>Fernando</given-names>
          </name>
          <degrees>MD, FAAP, FACMG</degrees>
          <aff>Professor, Department of Molecular and Human Genetics<break/>Baylor College of Medicine<break/>Houston, Texas</aff>
          <email>fscaglia@bcm.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>6</day>
          <month>12</month>
          <year>2012</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="tfr2" document-type="chapter">
<italic toggle="yes">TFR2</italic>-Related Hereditary Hemochromatosis</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="aec" document-type="chapter">
<italic toggle="yes">TP63</italic>-Related Disorders</related-object>
      <abstract id="tk2-mtddepl.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">TK2</italic>-related mitochondrial DNA (mtDNA) depletion syndrome is a phenotypic continuum that ranges from severe to mild. To date, approximately 45 individuals with a molecularly confirmed diagnosis have been reported.</p>
          <p>The most typical presentation, which occurs in infants and children, is progressive muscle disease characterized by generalized hypotonia, proximal muscle weakness, loss of previously acquired motor skills, poor feeding, and respiratory difficulties leading to respiratory failure and death within a few years after diagnosis. Other severe presentations include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Rapidly progressive proximal muscle weakness in newborns with encephalopathy, epilepsy, and early death;</p>
            </list-item>
            <list-item>
              <p>A spinal muscular atrophy-like presentation;</p>
            </list-item>
            <list-item>
              <p>Progressive myopathy with dystrophic changes (including sensorineural hearing loss);</p>
            </list-item>
            <list-item>
              <p>Hepatomegaly with elevated liver enzymes associated with the severe early-onset myopathy.</p>
            </list-item>
          </list>
          <p>Milder presentations include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Late-onset proximal muscle weakness and prolonged survival;</p>
            </list-item>
            <list-item>
              <p>Adult-onset forms with progressive mitochondrial myopathy;</p>
            </list-item>
            <list-item>
              <p>Chronic progressive external ophthalmoplegia with proximal muscle weakness associated with multiple mtDNA deletions and no mtDNA depletion.</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis is suspected in individuals with elevated serum creatine phosphokinase (CK) concentration (usually 5-10 times the upper limit of normal), and characteristic histopathologic findings in skeletal muscle as well as increased succinate dehydrogenase (SDH) activity and low-to-absent cytochrome <italic toggle="yes">c</italic> oxidase (COX) activity. Skeletal muscle typically shows severely reduced mitochondrial DNA (mtDNA) content (copy number) that is from 5% to 30% of tissue- and age-matched controls; however, mtDNA content ranging from 60% to normal has been reported. <italic toggle="yes">TK2</italic> is the only gene in which pathogenic variants are known to cause this disorder.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Management should involve a multidisciplinary team. Feeding difficulties should be managed aggressively, including use of a nasogastric tube or gastrostomy tube when the risk for aspiration is high. Physical therapy can help maintain muscle function and prevent joint contractures; a physical medicine and rehabilitation (PM&#x00026;R) specialist can help those who have difficulty walking. A pulmonologist can oversee chest physiotherapy to improve pulmonary function, reduce the risk of pulmonary infection, and manage respiratory insufficiency, if present.</p>
          <p><italic toggle="yes">Surveillance:</italic> Although no clinical guidelines are available, treating physicians should consider:</p>
          <list list-type="bullet">
            <list-item>
              <p>Beginning in infancy: periodic neurodevelopmental assessment and speech/language evaluation by developmental pediatrician or pediatric neurologist;</p>
            </list-item>
            <list-item>
              <p>Soon after diagnosis is established: routine assessments of nutritional status, weight gain, and growth parameters and routine pulmonary function tests, including assessment of blood gases, to monitor for respiratory insufficiency (i.e., alveolar hypoventilation and chronic hypercapnia).</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">TK2</italic>-related mtDNA depletion syndrome, myopathic form is inherited in an autosomal recessive manner. Each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible if the pathogenic variants in the family have been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="tk2-mtddepl.Diagnosis">
        <title>Diagnosis</title>
        <sec id="tk2-mtddepl.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p><italic toggle="yes">TK2</italic>-related mitochondrial DNA (mtDNA) depletion syndrome is a phenotypic continuum that ranges from severe to mild. The most typical presentation, which occurs in infants and children, is progressive muscle disease characterized by generalized hypotonia, proximal muscle weakness, loss of previously acquired motor skills, poor feeding, and respiratory difficulties leading to respiratory failure and death within a few years after diagnosis.</p>
          <p>Other severe presentations include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Rapidly progressive proximal muscle weakness in the newborn period with encephalopathy, epilepsy, and early death [<xref ref-type="bibr" rid="tk2-mtddepl.REF.lesko.2010.198">Lesko et al 2010</xref>]</p>
            </list-item>
            <list-item>
              <p>Spinal muscular atrophy-like presentation [<xref ref-type="bibr" rid="tk2-mtddepl.REF.pons.1996.153">Pons et al 1996</xref>]</p>
            </list-item>
            <list-item>
              <p>Progressive myopathy with dystrophic changes [<xref ref-type="bibr" rid="tk2-mtddepl.REF.collins.2009.784">Collins et al 2009</xref>]</p>
            </list-item>
            <list-item>
              <p>Sensorineural hearing loss at disease onset associated with progressive mitochondrial myopathy [<xref ref-type="bibr" rid="tk2-mtddepl.REF.mart_.2010.151">Mart&#x000ed; et al 2010</xref>]</p>
            </list-item>
            <list-item>
              <p>Hepatomegaly and elevated liver enzymes associated with progressive mitochondrial myopathy [<xref ref-type="bibr" rid="tk2-mtddepl.REF.zhang.2010.53">Zhang et al 2010</xref>]</p>
            </list-item>
          </list>
          <p>Milder presentations include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Late-onset proximal muscle weakness and prolonged survival [<xref ref-type="bibr" rid="tk2-mtddepl.REF.oskoui.2006.1122">Oskoui et al 2006</xref>]</p>
            </list-item>
            <list-item>
              <p>Adult-onset forms with progressive mitochondrial myopathy [<xref ref-type="bibr" rid="tk2-mtddepl.REF.b_hin.2012.644">B&#x000e9;hin et al 2012</xref>]. In addition to severe mtDNA depletion, multiple mtDNA deletions are also observed.</p>
            </list-item>
          </list>
        </sec>
        <sec id="tk2-mtddepl.Testing">
          <title>Testing</title>
          <p><bold>Serum creatine phosphokinase (CK) concentration</bold> is usually elevated 5-10 times the upper limit of normal; however, in affected individuals with severe muscle wasting, serum CK concentration can be normal.</p>
          <p>Note: Serum lactate as well as serum aminotransferases are usually normal.</p>
          <p><bold>Electromyography (EMG)</bold> is useful in distinguishing between a myopathic and neurogenic disorder; however, the findings are nonspecific as they occur in all myogenic disorders.</p>
          <p><bold>Pathology.</bold> Histopathologic findings on skeletal muscle include prominent variance in fiber size, sarcoplasmic vacuoles, and increased connective tissue. Ragged red fibers are invariably present. Succinate dehydrogenase (SDH) activity is increased; cytochrome <italic toggle="yes">c</italic> oxidase (COX) activity is low to absent.</p>
          <p>Electron microscopy shows abnormal mitochondria with circular cristae [<xref ref-type="bibr" rid="tk2-mtddepl.REF.lesko.2010.198">Lesko et al 2010</xref>].</p>
          <p><bold>Mitochondrial DNA (mtDNA) content (copy number) analysis in skeletal muscle.</bold> Mitochondrial DNA content is severely reduced, usually from 5% to 30% of tissue- and age-matched controls [<xref ref-type="bibr" rid="tk2-mtddepl.REF.dimmock.2010.1119">Dimmock et al 2010</xref>]; however, mtDNA content ranging from 60% to normal has been reported in rare cases [<xref ref-type="bibr" rid="tk2-mtddepl.REF.vil_.2003.1203">Vil&#x000e0; et al 2003</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.leshinskysilver.2008.309">Leshinsky-Silver et al 2008</xref>].</p>
          <p><bold>Electron transport chain (ETC) activity in skeletal muscle.</bold> Assays of ETC activity typically show decreased activity of multiple complexes with complex I, I+III, and IV being the most affected [<xref ref-type="bibr" rid="tk2-mtddepl.REF.pons.1996.153">Pons et al 1996</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.mancuso.2002.1197">Mancuso et al 2002</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.wang.2005.75">Wang et al 2005</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.galbiati.2006.177">Galbiati et al 2006</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.mart_.2010.151">Mart&#x000ed; et al 2010</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.b_hin.2012.644">B&#x000e9;hin et al 2012</xref>].</p>
          <sec id="tk2-mtddepl.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">TK2</italic> is the only gene in which pathogenic variants are known to cause <italic toggle="yes">TK2</italic>-related mitochondrial DNA depletion syndrome, myopathic form with isolated or highly predominant myopathy.</p>
            <table-wrap id="tk2-mtddepl.T.summary_of_molecular_genet" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">TK2</italic>-Related Mitochondrial DNA Depletion Syndrome, Myopathic Form</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_tk2-mtddepl.T.summary_of_molecular_genet_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_tk2-mtddepl.T.summary_of_molecular_genet_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_tk2-mtddepl.T.summary_of_molecular_genet_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_tk2-mtddepl.T.summary_of_molecular_genet_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_tk2-mtddepl.T.summary_of_molecular_genet_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">TK2</italic>
                    </td>
                    <td headers="hd_h_tk2-mtddepl.T.summary_of_molecular_genet_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup> / scanning for pathogenic variants&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_tk2-mtddepl.T.summary_of_molecular_genet_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_tk2-mtddepl.T.summary_of_molecular_genet_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;99%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_tk2-mtddepl.T.summary_of_molecular_genet_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_tk2-mtddepl.T.summary_of_molecular_genet_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Exon or whole-gene deletions</td>
                    <td headers="hd_h_tk2-mtddepl.T.summary_of_molecular_genet_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1%&#x000a0;<sup>7</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="tk2-mtddepl.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="tk2-mtddepl" object-id="tk2-mtddepl.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="tk2-mtddepl.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="tk2-mtddepl.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="tk2-mtddepl.TF.1.3">
                  <label>3. </label>
                  <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
                </fn>
                <fn id="tk2-mtddepl.TF.1.4">
                  <label>4. </label>
                  <p>Examples of pathogenic variants detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="tk2-mtddepl.TF.1.5">
                  <label>5. </label>
                  <p>Sequence analysis and scanning of the entire gene for pathogenic variants can have similar variant detection frequencies; however, variant detection rates for scanning may vary considerably between laboratories depending on the specific protocol used.</p>
                </fn>
                <fn id="tk2-mtddepl.TF.1.6">
                  <label>6. </label>
                  <p>Testing that identifies exon or whole-gene deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="tk2-mtddepl.TF.1.7">
                  <label>7. </label>
                  <p>One of approximately 45 affected individuals reported to date was found to have a 5.8-kb deletion in <italic toggle="yes">TK2</italic> by using custom oligonucleotide-based array CGH [<xref ref-type="bibr" rid="tk2-mtddepl.REF.zhang.2010.53">Zhang et al 2010</xref>]. The deletion extended from the 5&#x02019;UTR to intron 2 of <italic toggle="yes">TK2.</italic></p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="tk2-mtddepl.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <p><bold>Single-gene testing</bold>. One strategy for molecular diagnosis of an infant or child with progressive proximal muscle weakness and elevated CK concentration is the following:</p>
          <list list-type="order">
            <list-item>
              <label>1</label>
              <p>Perform a skeletal muscle biopsy. Because biallelic <italic toggle="yes">TK2</italic> pathogenic variants essentially impair the mtDNA content in muscle resulting in isolated progressive muscle weakness without symptoms or metabolic findings that suggest mitochondrial disease, the mtDNA depletion syndrome may well be missed if a muscle biopsy is not performed. If histopathologic and biochemical findings on skeletal muscle biopsy suggest mitochondrial disease and mtDNA depletion,</p>
            </list-item>
            <list-item>
              <label>2</label>
              <p>Perform mtDNA content analysis in skeletal muscle. If mtDNA copy number is severely reduced (typically &#x0003c;20% of age- and tissue-matched healthy controls),</p>
            </list-item>
            <list-item>
              <label>3</label>
              <p>Perform sequence analysis of the entire coding and exon/intron junction regions of <italic toggle="yes">TK2</italic>.</p>
              <list list-type="alpha-lower">
                <list-item>
                  <label>a</label>
                  <p>If compound heterozygous or homozygous deleterious variants are identified, the diagnosis is confirmed.</p>
                </list-item>
                <list-item>
                  <label>b</label>
                  <p>If sequence analysis does not identify two compound heterozygous or homozygous deleterious variants, deletion/duplication analysis should be considered [<xref ref-type="bibr" rid="tk2-mtddepl.REF.zhang.2010.53">Zhang et al 2010</xref>].</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Multi-gene panel.</bold> If the clinical presentation is highly suspicious for mtDNA depletion syndrome and it is not possible to obtain a muscle biopsy, molecular genetic testing using a panel of genes known to cause mtDNA depletion syndrome should be performed. See also <xref ref-type="sec" rid="tk2-mtddepl.Differential_Diagnosis">Differential Diagnosis</xref>. For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the pathogenic variants in the family.</p>
          <p>Note: Carriers are heterozygotes for this autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variants in the family.</p>
        </sec>
      </sec>
      <sec id="tk2-mtddepl.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="tk2-mtddepl.Clinical_Description">
          <title>Clinical Description</title>
          <p>The clinical presentation of <italic toggle="yes">TK2</italic>-related mtDNA depletion syndrome is variable; as understanding of the disorder increases, the phenotype continues to broaden (<xref ref-type="table" rid="tk2-mtddepl.T.clinical_manifestations_of">Table 2</xref>).</p>
          <p>To date, approximately 45 patients with molecularly confirmed <italic toggle="yes">TK2</italic>-related mtDNA depletion syndrome have been reported [<xref ref-type="bibr" rid="tk2-mtddepl.REF.pons.1996.153">Pons et al 1996</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.galbiati.2006.177">Galbiati et al 2006</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.oskoui.2006.1122">Oskoui et al 2006</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.blakely.2008.557">Blakely et al 2008</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.g_tz.2008.2841">G&#x000f6;tz et al 2008</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.collins.2009.784">Collins et al 2009</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.lesko.2010.198">Lesko et al 2010</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.mart_.2010.151">Mart&#x000ed; et al 2010</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.zhang.2010.53">Zhang et al 2010</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.b_hin.2012.644">B&#x000e9;hin et al 2012</xref>].</p>
          <p>The prenatal and perinatal histories are usually unremarkable; onset is typically in the first two years of life. Initial development is normal, followed by gradual onset of hypotonia. Subsequently generalized fatigue, decreased physical stamina, proximal muscle weakness (manifest as difficulty getting to standing or walking), and feeding difficulties develop. Muscle atrophy becomes evident [<xref ref-type="bibr" rid="tk2-mtddepl.REF.mart_.2010.151">Mart&#x000ed; et al 2010</xref>]. Some children develop bulbar weakness including dysarthria and dysphagia. Previously acquired motor skills are lost.</p>
          <p>Cognitive function is typically spared.</p>
          <p>Muscle weakness rapidly progresses leading to respiratory failure and death within a few years after onset. Most children succumb to complications of respiratory muscle weakness; several are ventilator dependent before age six years. The most common cause of death is pulmonary infection.</p>
          <p>Only a handful of affected individuals have survived to late childhood and adolescence.</p>
          <p><bold>Less frequent manifestations.</bold>
<italic toggle="yes">TK2</italic> pathogenic variants were previously thought to cause a purely myopathic form of mtDNA depletion syndrome; however, recent reports have expanded the clinical spectrum to include sensorineural hearing loss, chronic external ophthalmoplegia, early severe muscle weakness with encephalopathy and intractable epilepsy, and late-onset proximal muscle weakness and prolonged survival. In addition, one individual whose EMG showed denervation changes had a spinal muscular atrophy type 3-like presentation [<xref ref-type="bibr" rid="tk2-mtddepl.REF.pons.1996.153">Pons et al 1996</xref>].</p>
          <p>During the first year of life a few children with molecularly confirmed <italic toggle="yes">TK2</italic>-related mtDNA depletion syndrome have developed muscle weakness, elevated serum concentrations of aminotransferases and CK, and mtDNA depletion in muscle and liver.</p>
          <p>The observed elevation in serum transaminases may reflect skeletal muscle involvement [<xref ref-type="bibr" rid="tk2-mtddepl.REF.zhang.2010.53">Zhang et al 2010</xref>].</p>
          <table-wrap id="tk2-mtddepl.T.clinical_manifestations_of" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Clinical Manifestations of <italic toggle="yes">TK2</italic>-Related mtDNA Depletion Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_1" colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Clinical Manifestations</th>
                  <th id="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">Frequency</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Age of onset</bold>
                  </td>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_1" valign="top" align="left" rowspan="1" colspan="1">Age 0-2 years</td>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">38/45 (84%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_1" valign="top" colspan="1" align="left" scope="row" rowspan="1">Age &#x0003e;2 years</td>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">7/45 (16%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_1" rowspan="7" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Neurologic and neuromuscular findings</bold>
                  </td>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_1" valign="top" align="left" rowspan="1" colspan="1">Hypotonia, muscle weakness</td>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">45/45 (100%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_1" valign="top" colspan="1" align="left" scope="row" rowspan="1">Progressive external ophthalmoplegia</td>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">8/45 (17%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_1" valign="top" colspan="1" align="left" scope="row" rowspan="1">Seizures</td>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">6/45 (13%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_1" valign="top" colspan="1" align="left" scope="row" rowspan="1">Dysarthria</td>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">3/45 (6%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_1" valign="top" colspan="1" align="left" scope="row" rowspan="1">Facial muscle weakness</td>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">3/45 (6%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_1" valign="top" colspan="1" align="left" scope="row" rowspan="1">Dysphagia</td>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">2/45 (4%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_1" valign="top" colspan="1" align="left" scope="row" rowspan="1">Intellectual disability</td>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">2/45 (4%)</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Other</bold>
                  </td>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_1" valign="top" align="left" rowspan="1" colspan="1">Liver dysfunction</td>
                  <td headers="hd_h_tk2-mtddepl.T.clinical_manifestations_of_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">4/45 (8%)</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </sec>
        <sec id="tk2-mtddepl.GenotypePhenotype_Correlatio">
          <title>Genotype-Phenotype Correlations</title>
          <p>It is possible that the range of phenotypes observed may be explained by the variability in the amount of residual activity of mutant enzymes [<xref ref-type="bibr" rid="tk2-mtddepl.REF.poulton.2009">Poulton et al 2009</xref>].</p>
          <p>The small number of individuals reported to date precludes identifying genotype-phenotype correlations; however, the following have been observed:</p>
          <list list-type="bullet">
            <list-item>
              <p>The pathogenic variant <xref ref-type="table" rid="tk2-mtddepl.T.selected_tk2_pathogenic_va">p.Arg130Trp</xref> appears to be associated with the most severe phenotype, with CNS involvement during the first months of life.</p>
            </list-item>
            <list-item>
              <p>Homozygosity for <xref ref-type="table" rid="tk2-mtddepl.T.selected_tk2_pathogenic_va">p.Arg183Trp</xref> is associated with myopathy and severe mtDNA depletion restricted to skeletal muscle [<xref ref-type="bibr" rid="tk2-mtddepl.REF.g_tz.2008.2841">G&#x000f6;tz et al 2008</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="tk2-mtddepl.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of <italic toggle="yes">TK2</italic>-related mtDNA depletion syndrome is unknown; the disorder appears to be rare with only approximately 45 affected individuals reported to date.</p>
        </sec>
      </sec>
      <sec id="tk2-mtddepl.Genetically_Related_Allelic">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Two individuals with adult-onset chronic progressive external ophthalmoplegia and proximal muscle weakness who had biallelic <italic toggle="yes">TK2</italic> pathogenic variants were found to have multiple mtDNA deletions in skeletal muscle by Southern blot analysis; no mtDNA depletion was observed [<xref ref-type="bibr" rid="tk2-mtddepl.REF.tyynismaa.2012.66">Tyynismaa et al 2012</xref>].</p>
      </sec>
      <sec id="tk2-mtddepl.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The clinical presentation of this group of disorders is protean and may involve multiple organs.</p>
        <p>Biallelic pathogenic variants in one of the following genes can cause encephalopathy as well as myopathy:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="sucla2-def" document-type="chapter"><italic toggle="yes">SUCLA2</italic></related-object> (encoding ATP-dependent succinyl CoA synthase)</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="suclg1-mtddepl" document-type="chapter"><italic toggle="yes">SUCLG1</italic></related-object> (encoding GTP-dependent succinyl CoA synthase)</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="rrm2b-mtddepl" document-type="chapter"><italic toggle="yes">RRM2B</italic></related-object> (encoding p53-induced ribonucleotide reductase B subunit)</p>
          </list-item>
        </list>
        <p>The diagnosis is based on histopathology and mtDNA content analysis of affected tissues followed by molecular genetic testing.</p>
        <p>Biallelic pathogenic variants in <italic toggle="yes">TK2</italic> account for approximately 20% of the myopathic form of mtDNA depletion syndrome [<xref ref-type="bibr" rid="tk2-mtddepl.REF.mart_.2010.151">Mart&#x000ed; et al 2010</xref>].</p>
        <p>The differential diagnosis of <italic toggle="yes">TK2</italic>-related mtDNA depletion syndrome includes disorders that cause hypotonia and progressive proximal muscle weakness:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="pws" document-type="chapter"><bold>Prader-Willi syndrome</bold></related-object>
<bold>(PWS)</bold> is characterized by severe hypotonia and feeding difficulties in early infancy followed by improvement of muscle tone and excessive eating and obesity. PWS is caused by absence of the paternally derived PWS/Angelman syndrome (AS) region of chromosome 15 by one of several genetic mechanisms.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="sma" document-type="chapter"><bold>Spinal muscular atrophy</bold></related-object>
<bold>(SMA)</bold> is characterized by degeneration of the anterior horn cells of spinal cord. The age of onset ranges from early infancy to adulthood. Affected individuals typically develop severe and progressive muscle weakness involving respiratory muscles. The diagnosis of SMA is based on molecular genetic testing of the two genes associated with SMA, <italic toggle="yes">SMN1</italic> and <italic toggle="yes">SMN2</italic>.</p>
          </list-item>
          <list-item>
            <p><bold>Congenital myopathies</bold> (including <related-object link-type="booklink" source-id="gene" document-id="mtm" document-type="chapter">X-linked myotubular myopathy</related-object>, <related-object link-type="booklink" source-id="gene" document-id="cco" document-type="chapter">central core disease</related-object>, <related-object link-type="booklink" source-id="gene" document-id="mtm" document-type="chapter">centronuclear myopathy</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="nem" document-type="chapter">nemaline myopathy</related-object>) typically have normal or near-normal serum CK concentration and histologic evidence on muscle biopsy of developmental/structural muscle changes rather than dystrophic changes. The diagnosis is suggested by muscle biopsy and often can be confirmed by the results of molecular genetic testing.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="gsd2" document-type="chapter"><bold>Pompe disease</bold></related-object>
<bold>(glycogen storage disease 2)</bold> is characterized by progressive proximal muscle weakness early in the first few months of life accompanied with hypertrophic cardiomyopathy. The diagnosis is based on complete deficiency of activity of the enzyme alpha-glucosidase (GAA) (also called acid maltase) or detection of biallelic <italic toggle="yes">GAA</italic> pathogenic variants.</p>
          </list-item>
        </list>
        <p>See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS603041">Mitochondrial DNA depletion syndrome: OMIM Phenotypic Series</ext-link> to view genes associated with this phenotype in OMIM.</p>
      </sec>
      <sec id="tk2-mtddepl.Management">
        <title>Management</title>
        <sec id="tk2-mtddepl.Evaluations_Following_Initia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with <italic toggle="yes">TK2</italic>-related mitochondrial DNA depletion syndrome, myopathic form, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurology consultation with comprehensive neurologic examination</p>
            </list-item>
            <list-item>
              <p>Developmental evaluation</p>
            </list-item>
            <list-item>
              <p>Occupational therapy assessment, including oromotor functions such as chewing and swallowing</p>
            </list-item>
            <list-item>
              <p>Physical therapy consultation</p>
            </list-item>
            <list-item>
              <p>Consultation with a pediatric pulmonologist to evaluate pulmonary function</p>
            </list-item>
            <list-item>
              <p>Brain MRI in patients with encephalopathy or seizures</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="tk2-mtddepl.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Currently there is no definitive treatment. Management should involve a multidisciplinary team.</p>
          <p>Feeding difficulties should be managed aggressively, including use of a nasogastric tube or gastrostomy tube when the risk of aspiration is high.</p>
          <p>Physical therapy can help maintain muscle function and prevent joint contractures. A physical medicine and rehabilitation (PM&#x00026;R) specialist can be helpful for individuals with walking difficulty. As mobility becomes increasingly restricted, the use of a wheelchair should be considered.</p>
          <p>Early referral to a pediatric pulmonologist is recommended for assessment of pulmonary function and the need for chest physiotherapy to improve pulmonary function and reduce the risk of pulmonary infection. Pulmonary infection should be treated urgently in a standard manner to prevent deterioration in pulmonary function capacity. Once the patient becomes ventilator dependent due to respiratory compromise, chest physiotherapy can help reduce the risk of pulmonary infection.</p>
        </sec>
        <sec id="tk2-mtddepl.Surveillance">
          <title>Surveillance</title>
          <p>Although no clinical guidelines are available, treating physicians should consider the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Beginning in infancy: periodic neurodevelopmental assessment and speech/language evaluation by a developmental pediatrician or pediatric neurologist</p>
            </list-item>
            <list-item>
              <p>Soon after diagnosis is established:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Routine assessments of nutritional status, weight gain, and growth parameters</p>
                </list-item>
                <list-item>
                  <p>Routine pulmonary function tests, including assessment of blood gases, to monitor for respiratory insufficiency (alveolar hypoventilation and chronic hypercapnia)</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="tk2-mtddepl.Evaluation_of_Relatives_at_R">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="tk2-mtddepl.Related_Genetic_Counseling_I">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="tk2-mtddepl.Therapies_Under_Investigatio">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="tk2-mtddepl.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="tk2-mtddepl.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">TK2</italic>-related mtDNA depletion syndrome, myopathic form is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="tk2-mtddepl.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one mutated allele).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals with <italic toggle="yes">TK2</italic>-related mtDNA depletion syndrome, myopathic form have early-onset severe disease and do not survive to reproduce.</p>
            </list-item>
            <list-item>
              <p>If individuals with less severe manifestations of a<italic toggle="yes">TK2</italic>-related mtDNA depletion syndrome reproduce, their offspring are obligate heterozygotes for a <italic toggle="yes">TK2</italic> pathogenic variant.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="tk2-mtddepl.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk family members is possible if the pathogenic variants in the family have been identified.</p>
        </sec>
        <sec id="tk2-mtddepl.Related_Genetic_Counseling_I">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="tk2-mtddepl.Prenatal_Testing_and_Preimpl">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the pathogenic variants have been identified in the family, prenatal diagnosis for a pregnancy at increased risk and preimplantation genetic diagnosis are possible.</p>
        </sec>
      </sec>
      <sec id="tk2-mtddepl.Resources">
        <title>Resources</title>
      </sec>
      <sec id="tk2-mtddepl.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="tk2-mtddepl.Molecular_Genetic_Pathogenes">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Mitochondrial DNA (mtDNA) depletion syndrome is characterized by a significant reduction in the number of copies of mtDNA in one or more tissues. <italic toggle="yes">TK2</italic>, encoding thymidine kinase 2 (which mediates the first and rate-limiting step in the phosphorylation of deoxypyrimidine nucleosides in the mitochondrial matrix), was the first gene to be associated with the myopathic form of mtDNA depletion syndrome. To date, biallelic pathogenic variants in <italic toggle="yes">TK2</italic> account for approximately 20% of myopathic mtDNA depletion syndrome [<xref ref-type="bibr" rid="tk2-mtddepl.REF.mart_.2010.151">Mart&#x000ed; et al 2010</xref>].</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">TK2</italic> comprises ten coding exons. Alternate splicing results in multiple transcript variants (see <related-object source-id="gene" document-id="tk2-mtddepl" object-id="tk2-mtddepl.molgen.TA">Table A</related-object>, <bold>Gene</bold>). The longest transcript variant is <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004614.4">NM_004614.4</ext-link>.</p>
          <p><bold>Pathogenic variants.</bold> To date, 32 different <italic toggle="yes">TK2</italic> pathogenic variants have been reported in persons with myopathic mtDNA depletion (<xref ref-type="table" rid="tk2-mtddepl.T.selected_tk2_pathogenic_va">Table 3</xref>) [<xref ref-type="bibr" rid="tk2-mtddepl.REF.pons.1996.153">Pons et al 1996</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.galbiati.2006.177">Galbiati et al 2006</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.oskoui.2006.1122">Oskoui et al 2006</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.blakely.2008.557">Blakely et al 2008</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.g_tz.2008.2841">G&#x000f6;tz et al 2008</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.collins.2009.784">Collins et al 2009</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.lesko.2010.198">Lesko et al 2010</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.mart_.2010.151">Mart&#x000ed; et al 2010</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.zhang.2010.53">Zhang et al 2010</xref>, <xref ref-type="bibr" rid="tk2-mtddepl.REF.b_hin.2012.644">B&#x000e9;hin et al 2012</xref>].</p>
          <p>About 70% of reported pathogenic variants are missense; the remainder include nonsense and splice site variants and small (1-4 nucleotide) deletions and insertions.</p>
          <p>A large deletion spanning 5.8 kb has been reported [<xref ref-type="bibr" rid="tk2-mtddepl.REF.zhang.2010.53">Zhang et al 2010</xref>].</p>
          <p>All pathogenic variants are private except for the two variants p.Arg130Trp and p.Arg183Trp observed in affected individuals from Finland (<xref ref-type="table" rid="tk2-mtddepl.T.selected_tk2_pathogenic_va">Table 3</xref>) &#x02014; most likely founder variants in the Finnish population [<xref ref-type="bibr" rid="tk2-mtddepl.REF.g_tz.2008.2841">G&#x000f6;tz et al 2008</xref>].</p>
          <table-wrap id="tk2-mtddepl.T.selected_tk2_pathogenic_va" orientation="portrait" position="anchor">
            <label>Table 3. </label>
            <caption>
              <p>Selected <italic toggle="yes">TK2</italic> Pathogenic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Type of Pathogenic mtDNA Variant</th>
                  <th id="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_1" rowspan="21" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Missense variant</bold>
                  </td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.133C&#x0003e;T</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gln45Ter</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_4" rowspan="32" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004614.4">NM_004614.4</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_004605.4">NP_004605.4</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.159C&#x0003e;G</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ile53Met</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.173A&#x0003e;G</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Asn58Ser</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.191C&#x0003e;T</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Thr64Met</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.198C&#x0003e;G</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Cys66Trp</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.268C&#x0003e;T</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg90Cys</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.278A&#x0003e;G</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Asn93Ser</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.323C&#x0003e;T</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Thr108Met</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.334T&#x0003e;A</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr112Asn</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.361C&#x0003e;A</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.His121Asn</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.373C&#x0003e;T</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gln125Ter</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.389G&#x0003e;A</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg130Gln</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.388C&#x0003e;T</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg130Trp</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.416C&#x0003e;T</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ala139Val</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.547C&#x0003e;G</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg183Gly</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.547C&#x0003e;T</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg183Trp</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.562A&#x0003e;G</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Thr188Ala</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.575G&#x0003e;A</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg192Lys</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.635T&#x0003e;A</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ile212Asn</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.644T&#x0003e;C</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Leu215Pro</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.760C&#x0003e;T</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg254Ter</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Splicing variant</bold>
                  </td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.156+2T&#x0003e;C</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_1" rowspan="8" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Small deletion/insertion</bold>
                  </td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.129_132delAGAA</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Lys43AsnfsTer9</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.604_606delAAG</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Lys202del</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.8dupT</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Trp4ValfsTer40</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.142dupG</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.GluGly48fsTer102</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.150dupA</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ser51IlefsTer99</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.218_219dupCG</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Thr74ArgfsTer7</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.335_336dupAT</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Val113MetfsTer20</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.360_361delGCinsAA</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.His121Asn</td>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Gross deletion</bold>
                  </td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.1-495_283-2899del (5.8-kb del incl exons 1-2)</td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Complex rearrangement</bold>
                  </td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.-270+2561delins;7287-7335inv&#x000a0;<sup>1</sup></td>
                  <td headers="hd_h_tk2-mtddepl.T.selected_tk2_pathogenic_va_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="tk2-mtddepl.TF.3.1">
                <label>1. </label>
                <p>
                  <xref ref-type="bibr" rid="tk2-mtddepl.REF.stewart.2011">Stewart et al [2011]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> The TK2 isoform is 265 amino acids. <italic toggle="yes">TK2</italic> encodes thymidine kinase 2, the first and rate-limiting step in phosphorylation of deoxypyrimidine nucleosides (salvage pathway) in the mitochondrial matrix.</p>
          <p>Deoxynucloside triphosphate (dNTPs) can be synthesized via either the <italic toggle="yes">de novo</italic> pathway which is cell-cycle regulated or via the salvage pathway in which dNTPs are produced by utilizing pre-existing deoxynucleosides to synthesize DNA precursors. Both pathways may be required for mtDNA maintenance in post-mitotic tissues. Since mtDNA synthesis is continuous throughout the cell cycle, thymidine kinase 2 becomes indispensable for mtDNA maintenance.</p>
          <p><bold>Abnormal gene product.</bold>
<italic toggle="yes">TK2</italic> pathogenic variants result in dysfunction of the enzyme thymidine kinase 2 resulting in impaired synthesis of mtDNA precursors leading to mtDNA depletion.</p>
        </sec>
      </sec>
      <sec id="tk2-mtddepl.References">
        <title>References</title>
        <sec id="tk2-mtddepl.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="tk2-mtddepl.Literature_Cited.reflist0">
            <ref id="tk2-mtddepl.REF.b_hin.2012.644">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>B&#x000e9;hin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jardel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claeys</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fagart</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Louha</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laforet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lombes</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Adult cases of mitochondrial DNA depletion due to TK2 defect: an expanding spectrum.</article-title>
                <source>Neurology.</source>
                <year>2012</year>
                <volume>78</volume>
                <fpage>644</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22345218</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.blakely.2008.557">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blakely</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <article-title>Novel mutationin the TK2 gene associated with fatal mitochondrial DNA depletion myopathy.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2008</year>
                <volume>18</volume>
                <fpage>557</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">18508266</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.collins.2009.784">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bove</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dimmock</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morehart</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Progressive myofiber loss with extensive fibro-fatty replacement in a child with mitochondrial DNA depletion syndrome and novel thymidine kinase 2 gene mutations.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2009</year>
                <volume>19</volume>
                <fpage>784</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19736010</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.dimmock.2010.1119">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dimmock</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>LY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <article-title>Quantitative evaluation of the mitochondrial DNA depletion syndrome.</article-title>
                <source>Clin Chem.</source>
                <year>2010</year>
                <volume>56</volume>
                <fpage>1119</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">20448188</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.galbiati.2006.177">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Galbiati</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bordoni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papadimitriou</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toscano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodolico</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katsarou</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sciacco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garufi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aguennouz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonsignore</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crimi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinussi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresolin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papadimitriou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                </person-group>
                <article-title>New mutation in TK2 gene associated with mitochondrial DNA depletion.</article-title>
                <source>Pediatr Neurol.</source>
                <year>2006</year>
                <volume>34</volume>
                <fpage>177</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">16504786</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.g_tz.2008.2841">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>G&#x000f6;tz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isohanni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pihko</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paetau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herva</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saarenp&#x000e4;&#x000e4;-Heikkil&#x000e4;</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valanne</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marjavaara</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suomalainen</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>Thymidine kinase 3 defects can cause multi-tissue mtDNA depletion syndrome.</article-title>
                <source>Brain.</source>
                <year>2008</year>
                <volume>131</volume>
                <fpage>2841</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">18819985</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.leshinskysilver.2008.309">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leshinsky-Silver</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michelson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ginsberg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barash</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerman-Sagie</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lev</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>A defect in thymidine kinase 2 gene causing isolated mitochondrial myopathy without mtDNA depletion.</article-title>
                <source>Eur J Paediatr Neurol.</source>
                <year>2008</year>
                <volume>12</volume>
                <fpage>309</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">17951082</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.lesko.2010.198">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lesko</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naess</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wibom</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solaroli</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nennesmo</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Dobeln</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karlsson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsson</surname>
                    <given-names>NG</given-names>
                  </name>
                </person-group>
                <article-title>Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2010</year>
                <volume>20</volume>
                <fpage>198</fpage>
                <lpage>203</lpage>
                <pub-id pub-id-type="pmid">20083405</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.mancuso.2002.1197">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mancuso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salviati</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sacconi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otaegui</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camano</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moraes</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carlo</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-alvarez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monzon</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naini</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taratuto</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vu</surname>
                    <given-names>TH</given-names>
                  </name>
                </person-group>
                <article-title>Mitochondrial DNA depletion: mutation in thymidine kinase gene with myopathy and SMA.</article-title>
                <source>Neurology.</source>
                <year>2002</year>
                <volume>59</volume>
                <fpage>1197</fpage>
                <lpage>202</lpage>
                <pub-id pub-id-type="pmid">12391347</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.mart_.2010.151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mart&#x000ed;</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nascimento</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colomer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lara</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez-gallardo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz-Pesini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montaya</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreu</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briones</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pineda</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Hearing loss in a patient with the myopathic form of mitochondrial DNA depletion syndrome and novel mutation in the TK2 gene.</article-title>
                <source>Pediatr Res.</source>
                <year>2010</year>
                <volume>68</volume>
                <fpage>151</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20421844</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.oskoui.2006.1122">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oskoui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidzon</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erazo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurgel-Giannetti</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krishna</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dimauro</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Clinical spectrum of mitochondrial DNA depletion due to mutation in the thymidine kinase 2 gene.</article-title>
                <source>Arch Neurol.</source>
                <year>2006</year>
                <volume>63</volume>
                <fpage>1122</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16908738</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.pons.1996.153">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pons</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreetta</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vu</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <article-title>Mitochondrial myopathy simulating spinal muscular atrophy.</article-title>
                <source>Pediatr Neurol.</source>
                <year>1996</year>
                <volume>15</volume>
                <fpage>153</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8888051</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.poulton.2009">
              <mixed-citation publication-type="other">Poulton J, Hirano M, Spinazzola A, Arenas Hernandez M, Jardel C, Lomb&#x000e8;s A, Czermin B, Horvath R, Taanman JW, Rotig A, Zeviani M, Fratter C. Collated mutations in mitochondrial DNA (mtDNA) depletion syndrome (excluding the mitochondrial gamma polymerase, POLG1). Biochim Biophys Acta. 2009; 1792:1109-12.</mixed-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.stewart.2011">
              <mixed-citation publication-type="other">Stewart JD, Schoeler S, Sitarz KS, Horvath R, Hallmann K, Pyle A, Yu-Wai-Man P, Taylor RW, Samuels DC, Kunz WS, Chinnery PF. POLG mutations cause decreased mitochondrial DNA repopulation rates following induced depletion in human fibroblasts. Biochim Biophys Acta. 2011;1812:321-5.</mixed-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.tyynismaa.2012.66">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tyynismaa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahola-Erkkila</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Almusa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poyhonen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korpela</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Honkaniemi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isohanni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paetau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soumalainen</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2012</year>
                <volume>21</volume>
                <fpage>66</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">21937588</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.vil_.2003.1203">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vil&#x000e0;</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Segovia-Silvestre</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000e1;mez</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marina</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naini</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meseguer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lomb&#x000e8;s</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreu</surname>
                    <given-names>AL</given-names>
                  </name>
                </person-group>
                <article-title>Reversion of mtDNA depletion in a patient with TK2 deficiency.</article-title>
                <source>Neurology.</source>
                <year>2003</year>
                <volume>60</volume>
                <fpage>1203</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12682338</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.wang.2005.75">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Limongelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vila</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eriksson</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2005</year>
                <volume>84</volume>
                <fpage>75</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">15639197</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.zhang.2010.53">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>FY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bass</surname>
                    <given-names>HN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pursley</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brundage</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mardach</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <article-title>Application of oligonucleotide array CGH to the simultaneous detection of a deletion in the nuclear TK2 gene and mtDNA depletion.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2010</year>
                <volume>99</volume>
                <fpage>53</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19815440</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="tk2-mtddepl.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="tk2-mtddepl.Suggested_Reading.reflist0">
            <ref id="tk2-mtddepl.REF.akman.2008.2433">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Akman</surname>
                    <given-names>HO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorado</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-cazorla</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vila</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanabe</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dauer</surname>
                    <given-names>WT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanji</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleoside pools for mitochondrial DNA maintenance.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2008</year>
                <volume>17</volume>
                <fpage>2433</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">18467430</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.bartesaghi.2010.1669">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bartesaghi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Betts-Henderson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cain</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinsdale</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karlsson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solomoni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicotera</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Loss of thymidine kinase 2 alters neuronal bioenergetics and leads to neurodegeneration.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2010</year>
                <volume>19</volume>
                <fpage>1669</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">20123860</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.mancuso.2003.1007">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mancuso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filosto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>VU TH, DiMauro S. Mitochondrial myopathy of childhood associated with mitochondrial DNA depletion and a homozygous mutation (T77M) in the TK2 gene.</article-title>
                <source>Arch Neurol.</source>
                <year>2003</year>
                <volume>60</volume>
                <fpage>1007</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12873860</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.nevo.2002.499">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nevo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soffer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kutai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zelnik</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saada</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jossiphov</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaag</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shahar</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elpeleg</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <article-title>Clinical characteristics and muscle pathology in myopathic mitochondrial DNA depletion.</article-title>
                <source>J child Neurol.</source>
                <year>2002</year>
                <volume>17</volume>
                <fpage>499</fpage>
                <lpage>504</lpage>
                <pub-id pub-id-type="pmid">12269728</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.saada.2003.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Saada</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaag</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elpeleg</surname>
                    <given-names>O.</given-names>
                  </name>
                </person-group>
                <article-title>mtDNA depletion myopathy: elucidation of the tissue specificity in the mitochondrial thymidine kinase (TK2) deficiency.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2003</year>
                <volume>79</volume>
                <fpage>1</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12765840</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.suomalainen.2010.429">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Suomalainen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isohanni</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>Mitochondrial DNA depletion syndrome-many genes, common mechanisms.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2010</year>
                <volume>20</volume>
                <fpage>429</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">20444604</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.tulinius.2005.412">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tulinius</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moslemi</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holme</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldfor</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Novel mutations in the thymidine kinase 2 gene (TK2) associated with fatal mitochondrial myopathy and mitochondrial DNA depletion.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2005</year>
                <volume>15</volume>
                <fpage>412</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15907288</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.vu.1998.1190">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vu</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanji</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valsamis</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Mitochondrial DNA depletion in a patient with long survival.</article-title>
                <source>Neurology.</source>
                <year>1998</year>
                <volume>51</volume>
                <fpage>1190</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">9781557</pub-id>
              </element-citation>
            </ref>
            <ref id="tk2-mtddepl.REF.zhou.2008.2329">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solaroli</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bjerke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rozell</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johansson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karlsson</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Progressive loss of mitochondrial DNA in thymidine kinase 2-deficient mice.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2008</year>
                <volume>17</volume>
                <fpage>2329</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">18434326</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="tk2-mtddepl.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="tk2-mtddepl.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>6 December 2012 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>23 August 2012 (fs) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
